Emile J.M. Rijcken

Dr. Emile J.M. Rijcken

Department of General -, Visceral- and Transplantation Surgery, Muenster University Hospital, Muenster, Germany

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2012 in Diseases of the Colon & Rectum
Verified
Journal Article
Closed access
EREmile J.M. Rijcken
Emile J.M. Rijcken
RMRudolf Mennigen
Rudolf Mennigen
IAIoannis Argyris
Ioannis Argyris
NSNorbert Senninger
Norbert Senninger
MBMatthias Bruewer
Matthias Bruewer
Single-incision laparoscopic surgery is a development in the field of minimally invasive surgery that is being increasingly used for colorectal procedures. We report on the short-term results of single-port laparoscopic ileocolic resection in patients with ileocecal Crohn's disease. This investigation is a retrospective matched-pair control study. Data were obtained from a prospectively maintained single-institution inflammatory bowel disease database. This study was conducted at a tertiary care university hospital. Twenty consecutive patients receiving elective single-port ileocolic resection between April 2010 and May 2011 were included (6 male, 14 female; age, 31.6 ± 10.8 years; BMI, 21.5 ± 2.6 kg/m2). Their data were compared with the data of 20 individually matched patients who had undergone standard 3-trocar laparoscopic-assisted ileocolic resection between 2007 and 2010 (6 male, 14 female; age, 31.7 ± 10.7 years; BMI, 21.2 ± 2.5 kg/m2). All patients had medically refractory stenosis of the terminal ileum in histologically confirmed Crohn's disease. Single-port laparoscopic-assisted or standard laparoscopic-assisted ileocolic resection was performed. The primary outcomes measured were the surgical details and early outcome. The mean length of the paraumbilical single-port incision was 3.8 cm (range, 2.5–5.0 cm). Conversion rates were similar in both groups (1/20 vs 2/20, p = 0.55). Additional strictureplasties or short-segment small-bowel resections were performed in both groups. The overall complication rate was 20% (4/20) in both groups. There were no observed differences in postoperative pain scores and hospital stay duration. The limitations of this study were as follows: this study was a comparison of 2 different time points with possible selection bias, there was no prestudy power calculation, and the study might be underpowered. Single-port ileocolic resection is a safe procedure for the surgical treatment of stenotizing Crohn's disease of the terminal ileum. Avoidance of additional trocars was the only identified benefit.

1 July 2017 in Journal of Surgical Education
Verified
Journal Article
Closed access
CBChristian Brinkmann
Christian Brinkmann
MFMathias Fritz
Mathias Fritz
UPUlrich Pankratius
Ulrich Pankratius
RBRalf Bahde
Ralf Bahde
PNPhilipp Neumann
Philipp Neumann
EREmile J.M. Rijcken
Emile J.M. Rijcken

1 March 2014 in Journal of Surgical Research
Verified
Journal Article
Closed access
EREmile J.M. Rijcken
Emile J.M. Rijcken
LSLarissa Sachs
Larissa Sachs
TFThomas Fuchs
Thomas Fuchs
HSHans-Ullrich Spiegel
Hans-Ullrich Spiegel
PNPhilipp-Alexander Neumann
Philipp-Alexander Neumann

1 August 2007 in American Journal of Physiology-Gastrointestinal and Liver Physiology
Verified
Journal Article
Closed access
PDF file
EREmile J.M. Rijcken
Emile J.M. Rijcken
RMRudolf B. Mennigen
Rudolf B. Mennigen
SSSebastian D. Schaefer
Sebastian D. Schaefer
MLMike G. Laukoetter
Mike G. Laukoetter
CAChristoph Anthoni
Christoph Anthoni
CKChristian F. Krieglstein
Christian F. Krieglstein
Transendothelial migration of circulating leukocytes into the colonic wall is a key step in the development of the inflammatory infiltrate in inflammatory bowel disease (IBD). The platelet-endothelial cell adhesion molecule-1 PECAM-1 (CD31) is expressed in the tight junction area of endothelial cells, where it is supposed to support the transmigration process. The aim of this study was to determine the role of PECAM-1 in experimental IBD and to show whether blockade of PECAM-1 has therapeutic effects. Chronic colitis was induced in female BALB/c mice by cyclic oral administration of dextran sodium sulfate (DSS) 3% (wt/vol). Expression of PECAM-1 was visualized by immunohistochemistry. In the treatment group animals received 1 mg/kg anti-PECAM-1 (2H8) ip daily starting on day 26. On day 30 leukocyte adhesion and migration was measured during N2O-isoflurane anesthesia in the distal colon by intravital microscopy. Disease activity index (DAI), histology, and MPO levels were compared with healthy and diseased controls. PECAM-1 was expressed in colitic mice. Chronic DSS colitis was characterized by a marked increase in rolling, adherent, and transmigrated leukocytes compared with healthy controls. Immunoblockade of PECAM-1 reduced leukocyte transmigration significantly and also diminished leukocyte rolling and sticking in an indirect manner. It also resulted in a significantly diminished DAI and MPO levels, as well as an amelioration of the histological inflammation score. PECAM-1 plays an important role in transendothelial leukocyte migration in DSS colitis. PECAM-1 could be a novel target for antibody-based treatment in IBD.

1 December 2014 in International Journal of Surgery
Verified
Journal Article
Closed access
EREmile J.M. Rijcken
Emile J.M. Rijcken
SMSoeren Torge Mees
Soeren Torge Mees
GBGuido Bisping
Guido Bisping
KKKristin Krueger
Kristin Krueger
MBMatthias Bruewer
Matthias Bruewer
RMRudolf Mennigen
Rudolf Mennigen
Laparoscopic splenectomy has been proposed to be the standard therapy for adult patients with medically refractory immune thrombocytopenia (ITP). However, due to inconsistent definitions of response, variable rates of long term response have been reported. Furthermore, new medical treatment options are currently challenging the role of splenectomy. The aims of this study were to (1) analyze long term response after splenectomy according to recently defined consensus criteria, (2) identify possible predictive response factors. A case series of 72 consecutive patients with ITP undergoing laparoscopic splenectomy was retrospectively studied using univariate and multivariate analysis as well as logrank tests. Median follow-up was 32 (2-110) months. Mortality was 0% and morbidity was 8.2%. Response to splenectomy was achieved in of 63/72 patients (87.5%). Loss of response occurred in 19/63 (30.2%) in median after 3 (range 2-42) months. Preoperative platelet counts after boosting with steroids and immunoglobulins as well as the postoperative rise in platelet counts were statistically significant factors for response upon both univariate and multivariate analysis, whereas age, gender, body mass index, ASA classification, disease duration, accessory spleens, splenic weight, conversion to open surgery, or perioperative complications were not. Patients with a postoperative rise in platelet counts >150,000/μL had a significant better chance on stable long term response than those with a smaller increment (P < 0.001). Laparoscopic splenectomy is an effective and safe treatment option in order to obtain stable long term response in patients with ITP. Perioperative platelet counts are predictive factors of long term response.

1 January 2016 in World Journal of Gastrointestinal Pharmacology and Therapeutics
Verified
Journal Article
Open access
PNPhilipp-Alexander Neumann
Philipp-Alexander Neumann
EREmile J.M. Rijcken
Emile J.M. Rijcken
Patients with inflammatory bowel disease (IBD) comprise a population of patients that have a high likelihood of both surgical treatment at a young age and repetitive operative interventions. Therefore surgical procedures need to aim at minimizing operative trauma with best postoperative recovery. Minimally invasive techniques have been one of the major advancements in surgery in the last decades and are nowadays almost routinely performed in colorectal resections irrespective of underlying disease. However due to special disease related characteristics such as bowel stenosis, interenteric fistula, abscesses, malnutrition, repetitive surgeries, or immunosuppressive medications, patients with IBD represent a special cohort with specific needs for surgery. This review summarizes current evidence of minimally invasive surgery for patients with Crohn’s disease or ulcerative colitis and gives an outlook on the future perspective of technical advances in this highly moving field with its latest developments in single port surgery, robotics and trans-anal techniques.